Adenosine A2A receptor-mediated cell death of mouse thymocytes involves adenylate cyclase and Bim and is negatively regulated by Nur77

European Journal of Immunology

Volumn 36, Issue 6, 2006, Pages 1559-1571

  Kiss, Ildikó ^a   Oskolás, Henriett ^a   Tóth, Réka ^a   Bouillet, Philippe ^b   Tóth, Katalin ^a   Fülöp, András ^a   Scholtz, Beáta ^a   Ledent, Catherine ^c   Fésüs, László ^a   Szhondy, Zsuzsa ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Adenosine; Apoptosis; Bim; Nur77; Thymocytes

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR; ADENYLATE CYCLASE; BH3 PROTEIN; BIM PROTEIN; DEATH RECEPTOR; FAS LIGAND; NUCLEAR RECEPTOR NUR77; PROTEIN BCL 2; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; BID PROTEIN, MOUSE; CELL RECEPTOR; CYCLIC AMP; DNA BINDING PROTEIN; FASL PROTEIN, MOUSE; MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN BID; STEROID RECEPTOR; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOACCUMULATION; CELL DEATH; CELL KILLING; CELL LINE; CELL MATURATION; CELL SELECTION; CONTROLLED STUDY; ENZYME ACTIVATION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; THYMOCYTE; TRANSGENIC MOUSE; ANIMAL; APOPTOSIS; C57BL MOUSE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENETICS; IMMUNOLOGY; MOUSE MUTANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; WESTERN BLOTTING;

ADENOSINE; ADENYLATE CYCLASE; ANIMALS; APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; BLOTTING, WESTERN; CYCLIC AMP; DNA-BINDING PROTEINS; FAS LIGAND PROTEIN; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, ADENOSINE A2A; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTORS;

EID: 33745415195     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535334     Document Type: Article

References (60)

1. Kellems, R. E., Yeung, C.-Y. and Ingolia, D. E., Adenosine deaminase deficiency and severe combined immunodeficiencies. Trends Genet. 1985. 1: 278-286.
2. Apasov, S., Koshiba, M., Redegeld, F. and Sitkovsky, M., Role of extracellular ATP and P1 and P2 classes purinergic receptors in T-cell development and cytotoxic effector functions. Immunol. Rev. 1995. 146: 5-19.
3. Sitkovsky, M. V., Lukashev, D., Apasov, S., Kojima, H., Koshiba, M., Caldwell, C., Ohta, A. and Thiel, M., Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu. Rev. Immunol. 2004. 22: 657-682.
4. Cronstein, B. N., A novel approach to the development of antiinflammatory agents: Adenosine release at the inflamed sites. J. Invest. Med. 1995. 43: 50-57.
5. Oláh, M. E. and Stiles, G., Adenosine receptor subtypes: Characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol 1995. 35: 581-606.
6. Kizaki, H., Suzuki, K., Tadakuma, T. and Ishimura, Y., Adenosine-receptor-mediated accumulation of cyclic AMP-induced T-lymphocyte death through internucleosomal DNA cleavage. J. Biol. Chem. 1990. 265: 5280-5284.
7. 2+-mediated mechanisms. Biochem. J. 1994. 304: 877-885.
8. Szondy, Z., Methylprednisolone and 2-chloroadenosine induce DNA fragmentation at different stages of human T-lymphocyte development. Immunol. Lett. 1997. 58: 59-65.
9. Plaut, M., Lymphocyte hormone receptors. Annu. Rev. Immunol. 1987. 5: 621-569.
10. Fredholm, B. B., Arslan, G., Halldner, L., Kull, B., Schulte, G. and Wasserman, W., Structure and function of adenosine receptors and their genes. Naunyn-Schmiedeberg's Arch. Pharmacol 2000. 362: 364-374.
11. Woronicz, J. D., Calnan, B., Ngo, V. and Winoto, A., Requirement for the orphan steroid receptor Nur77 in apoptosis of T cell hybridomas. Nature 1994. 367. 277-281.
12. Liu, Z. G., Smith, S. W., McLaughlin, K. A., Schwartz, L. M. and Osborne, B. A., Apoptotic signals delivered through the T-cell receptor of a T cell hybrid require the immediate-early gene Nur77. Nature 1994. 367. 281-284.
13. Kuang, A. A., Cado, D. and Winoto, A., Nur77 transcription activity correlates with its apoptotic function in vivo. Eur. J. Immunol. 1999. 29: 3722-3728.
14. Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B. et al., The nuclear receptor superfamily: the second decade. Cell 1995. 83: 835-839.
15. Wilson, T. E., Fahrner, T. J. and Milbrandt, J., The orphan receptors NGFI-B and steroidiogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction. Mol. Cell. Biol. 1993. 13: 5794-5804.
16. Philips, A., Lesage, S., Gingras, R., Maira, M.-H., Gauthier, Y., Hugo, P. and Drouin, J., Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Mol. Cell. Biol. 1997. 17: 5946-5951.
17. Perlmann, T. and Jansson, L., A novel pathway for vitamin A signalling mediated by RXR heterodimerisation with NGFI-B and NURR1. Genes Dev. 1995. 9: 769-782.
18. Woronicz, J. D., Lina, A. Calnan, B. J., Szychowski, S., Cheng, L. and Winoto, A., Regulation of the Nur77 orphan steroid receptor in activation-induced apoptosis. Mol. Cell. Biol. 1995. 15: 6364-6376.
19. Calnan, B. J., Szychowski, S., Chan, F. K. M., Cado, D. and Winoto, A., A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity 1995. 3: 273-282.
20. Zhou, T., Cheng, J., Yang, Z., Liu, C., Su, X., Bluethmann, H. and Mountz, J. D., Inhibition of Nur77/Nurr1 leads to inefficient clonal deletion of self-reactive T cells. J. Exp. Med. 1996. 183: 1879-1892.
21. Weih, F., Ryseck, R. P., Chen, L. and Bravo, R., Apoptosis of Nur77/ N10-transgenic thymocytes involves the Fas/Fas ligand pathway. Proc. Natl. Acad. Sci. USA 1996. 93: 5533-5538.
22. Rajpal, A., Cho, Y. A., Yelent, B., Koza-Taylor, P. H., Li, D., Chen, E., Whang, M. et al., Transcriptional activation of known and novel apoptotic pathways by Nur77 orphan steroid receptor. EMBO J. 2003. 22: 6526-6536.
23. Lin, B., Kolluri, S. K., Lin, F., Liu, W., Han, Y. H., Cao, X., Dawson, M. I. et al., Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 2004. 116: 527-540.
24. Kim, S. O., Oho, K., Tobias, P. S. and Han, J., Orphan nuclear receptor Nur77 is involved in caspase-independent macrophage cell death. J. Exp. Med. 2003. 197: 1441-1452.
25. Bras, A., Albar, J. P., Leonardo, E., de Buitrago, G. G. and Martinez, A. C., Ceramide-induced cell death is independent of the Fas/Fas ligand pathway and is prevented by Nur77 overexpression in A20 B cells. Cell Death Differ. 2000. 7: 262-271.
26. Suzuki, S., Suzuki, N., Mirtsos, C., Horacek, T., Lye, E., Noh, S. K., Ho, A. et al., Nur77 as a survival factor in tumor necrosis factor signaling. Proc. Natl. Acad. Sci. USA 2003. 100: 8276-8280.
27. de Léséluc, L. and Denis, F., Inhibition ofapoptosis by Nur77 through NFκB activity modulation. Cell Death Differ. 2006. 13: 293-300.
28. Bouillet, P., Metcalf, D., Huang, D. C. S., Tarlinton, D. M., Kay, T. W. H., Kontgen, F., Adams, J. M. and Strasser, A., Proapoptotic bcl-2 relative bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999. 286: 1735-1738.
29. O'Connor, L., Strasser, A., O'Reilly, L. A., Haussmann G., Adams, J. M., Cory, S. and Huang, D. C. S., Bim- a novel member of the bcl-2 family that promotes apoptosis. EMBO J. 1998. 17: 384-395.
30. O'Reilly, L. A., Cullen, L., Visvader, J., Lindeman, G. J., Print, C., Bath, M. L., Huang, D. C. S. and Strasser, A., The proapoptotic BH3-only protein bim is expressed in hematopoietic, epithelial, neuronal, and germ cells. Am. J. Pathol. 2000. 157. 449-461.
31. Bouillet, P., Purton, J. F., Godfrey, D. I., Zhang, L. C., Coultas, L., Puthalakath, H., Pellegrini, M. et al., BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 2002. 415: 922-926.
32. Szegezdi, E., Kiss, I., Simon, A., Blasko, B., Reichert, U., Michel, S., Sandor, M. et al., Ligation of retinoic acid receptor alpha regulates negative selection of thymocytes by inhibiting both DNA binding of Nur77 and synthesis of bim. J. Immunol. 2003. 170: 3577-3584.
33. 2A-receptor-gene-deficient mice. Biochem. J. 2001. 354: 123-130.
34. Pass, D. M., Butler, J. E. and Goodman, R. H., Deacetylase activity is required for cAMP activation of a subset of CREB target genes. J. Biol. Chem. 2003. 278: 43014-43019.
35. Youn, H. D. and Liu, J. O., Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2. Immunity 2000. 13: 85-94.
36. Ledent, C., Vaugeois, J. M., Schiffmann, S. N., Pedrazzini, T., El Yacoubi, M., Vanderhaeghen, J. J., Costentin, J. et al., Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 1997. 388: 674-678.
37. Cassel, D. and Selinger, Z., Mechanism of adenylate cyclase activation by cholera toxin: inhibition of GTP hydrolysis at the regulatory site. Proc. Natl. Acad. Sci. USA 1977. 74: 3307-3311.
38. Seamon, K. B., Padgett, W. and Daly, J. W., Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc. Natl. Acad. Sci. USA 1981. 78: 3363-3367.
39. Skalhegg, B. S. and Tasken, K., Specificity in the cAMP/PKA signaling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA. Front. Biosci. 2000. 5: D678-693.
40. van Hassert, P. J. M., van Driel, R., Jastorff, B., Baraniak J., Stec, W. J. and De Wit, R. J. W., Competitive cAMP antagonists for cAMP-receptor proteins. J. Biol. Chem. 1984. 259: 10020-10024.
41. Kristie, T. M. and Roizman, B., DNA-binding site of major regulatory protein alpha 4 specifically associated with promoter regulatory domains of alpha genes of herpes simplex virus type 1. Proc. Natl. Acad. Sci. USA 1986. 83: 4700-4704.
42. Tóth, R., Szegezdi, E., Molnar, G., Lord, J. M., Fésüs, L. and Szondy, Z., Regulation of cell surface expression of Fas (CD95) ligand and susceptibility to Fas (CD95)-mediated apoptosis in activation-induced T cell death involves calcineurin and protein kinase C, respectively. Eur. J. Immunol. 1999. 29: 383-393.
43. -/- mice. Nat. Immunol. 2003. 4: 255-260.
44. Newton, K., Harris, A. W., Bath, M. L., Smith, K. G. C. and Strasser, A., A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 1998. 17: 706-718.
45. Lee, S. L., Wesselschmidt, R. L., Linette, G. P., Kanagawa, O., Russel, J. H. and Milbrandt J., Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B (Nur77). Science 1995. 269: 532-535.
46. Ogilvy, S., Metcalf, D., Print, C. G., Bath, M. L., Harris, A. W. and Adams, J. M., Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc. Natl. Acad. Sci. USA 1999. 96: 14943-14948.
47. Strasser, A., Harris, A. W. and Cory, S., Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 1991. 67. 889-899.
48. Surh, C. D. and Sprent, J., T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 1994. 372: 100-103.
49. Chan, T., Purine excretion by mouse peritoneal macrophages lacking adenosine deaminase activity. Proc. Natl. Acad. Sci. USA 1979. 76: 925-929.
50. Blackburn, M. R., Datta, S. K., Wakamiya, M., Vartabedian, B. S. and Kellems, R. E., Metabolic and immunologic consequences of limited adenosine deaminase expression in mice. J. Biol. Chem. 1996. 271: 15203-15210.
51. Hershfield, M. S. and Mitchell, B. S., Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. In Scriver, C. R., Beaudet, A. L., Sly, W. S. and Valle, D. (Eds.) The metabolic and molecular bases of inherited disease. McGraw-Hill Inc., New York 1995, pp 1725-1738.
52. Van De Wiele, C. J., Vaughn, J. G., Blackburn, M. R., Ledent, C. A., Jacobson, M., Jiang, H. and Thompson, L. F., Adenosine kinase inhibition promotes survival of fetal adenosine deaminase-deficient thymocytes by blocking dATP accumulation. J. Clin. Invest. 2002. 110: 395-402.
53. Drumm, D., Hoefer, M., Juhasz, J., Huszar, E. and Sybrecht, G. W., Plasma adenosine during investigation of hypoxic ventilatory response. Sleep Breath. 2004. 8: 31-51.
54. Fernandez, P. M., Brunel, F., Jimenez, M. A., Saez, J. M., Cereghini, S. and Zakin, M., Nuclear receptors Nor1 and NGFI-B/Nur77 play similar, albeit distinct, roles in the hypothalamo-pituitary-adrenal axis. Endicronology 2000. 141: 2392-2400.
55. Li, Y., Lin, B., Agadir, A., Liu, R., Dawson, M. I., Reed, J. C., Fontana, J. A. et al., Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer lines. Mol. Cell Biol. 1998. 18: 4719-4731.
56. Li, H., Kolluri, S. K., Gu, J., Dawson, M. I., Cao, X., Hobbs, P. D., Lin, B. et al., Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear receptor TR3. Science 2000. 289: 1159-1164.
57. Zhang, L. and Insel, P. A., The pro-apoptotic protein bim is a convergence point for cAMP/protein kinase A- and glucocorticoid-promoted apoptosis in lymphoid cells. J. Biol. Chem. 2004. 279: 20858-20865.
58. Villunger, A., Marsden, V. S., Zhan, Y., Erlacher, M., Lew, A. M., Bouillet, P., Berzins, S. et al., Negative selection of semimature CD4(+)8(-)HSA(+) thymocytes requires the BH3-only protein Bim but is independent of death receptor signaling. Proc. Natl. Acad. Sci. USA 2004. 101: 7052-7057.
59. Cretney, E., Uldrich, A. P., Berzins, S. P., Strasser, A., Godfrey, D. I. and Smyth, M. J., Normal thymocyte negative selection in TRAIL-deficient mice. J. Exp. Med. 2003. 198: 491-496.
60. 2+ indicators with greatly improved fluorescent properties. J. Biol. Chem. 1985. 260: 3440-3450.